Patents by Inventor Rémy Sadoul

Rémy Sadoul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Combined treatment of multiple sclerosis
    Patent number: 6869600
    Abstract: The use of growth hormone (GH) together with an interferon (IFN) to produce a pharmaceutical composition for treating multiple sclerosis and/or other demyelinating diseases is disclosed. Disclosed are also pharmaceutical compositions for treating multiple sclerosis and/or other demyelinating diseases. Disclosed are also pharmaceutical compositions for the simultaneous, separate or sequential use of its active ingredients for the above specified therapy. In particular, the advantage of EP0003504 of GH together with IFN-? to produce a pharmaceutical composition for the treatment of multiple sclerosis are shown.
    Type: Grant
    Filed: March 20, 2000
    Date of Patent: March 22, 2005
    Assignee: Applied Research Systems ARS Holding N.V.
    Inventors: Rémy Sadoul, Sonia Pagliusi
  • Bax protein channel formation
    Patent number: 6022720
    Abstract: The present invention relates, in general, to a protein that regulates programmed cell death and, in particular, to the pro-apoptotic protein, Bax, which forms channels in lipid membranes. The invention further relates to methods of identifying agonists and antagonists of Bax channel formation and/or activity and thereby agents that can be used therapeutically to promote or inhibit cell death.
    Type: Grant
    Filed: July 17, 1997
    Date of Patent: February 8, 2000
    Assignee: Glaxo Wellcome Inc.
    Inventors: Jean-Claude Martinou, Remy Sadoul, Bruno Antonsson, Franco Conti, Gonzalo Mazzei